Targeted brain stimulation for treatment-resistant depression
Part of Mental health clinical trials.
This study tests a new way of delivering brain stimulation called rTMS to treat depression that hasn't improved with standard treatments. The goal is to see if targeting specific brain areas helps reduce depression symptoms more effectively.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with major depressive disorder, and your current episode is confirmed by a standard interview.
- You have tried at least two different depression treatments (like medications) that did not give you at least 50% improvement.
- Your depression must be at least moderate in severity, which we will check with a rating scale.
- You cannot have ever had bipolar disorder, schizophrenia, or another psychotic disorder.
- You cannot have certain metal implants or conditions that make MRI unsafe, and you must not have severe claustrophobia.
- You cannot be pregnant or breastfeeding, and if you can become pregnant, you must agree to use birth control.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two fast types of brain stimulation (called accelerated theta burst stimulation) to see which works better for people whose depression hasn't improved with standard antidepressants. It's designed for people with treatment-resistant depression who are already on a stable antidepressant.
This trial tests a new type of brain stimulation treatment for people with major depression that hasn't improved with standard treatments. The treatment uses magnetic pulses to target specific brain areas over about 2 weeks.
This study is testing whether a new type of brain stimulation called intermittent theta burst stimulation (iTBS) can help people with treatment-resistant depression (depression that hasn't improved with standard medicines). It also looks at certain blood markers to see if they can predict how well someone will respond to this treatment.
This trial tests an alternating combination of brain stimulation and brain imaging to see if it helps people with depression that hasn’t improved with usual treatments. The goal is to find a safer, more effective approach for people whose depression has been very difficult to treat.
This study uses brain imaging to guide a noninvasive treatment called transcranial magnetic stimulation (TMS) for people with depression. It aims to see if tailoring the stimulation to each person's brain can improve symptoms.
This study tests a new type of magnetic brain stimulation (called theta burst stimulation) for people whose depression hasn't improved with standard treatments. It aims to see if this treatment is safe and effective for both adults and teenagers with moderate to severe depression.
Hear when a new Treatment Resistant Depression (TRD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.